UY29237A1 - Metodos detratamiento y prevencion - Google Patents

Metodos detratamiento y prevencion

Info

Publication number
UY29237A1
UY29237A1 UY29237A UY29237A UY29237A1 UY 29237 A1 UY29237 A1 UY 29237A1 UY 29237 A UY29237 A UY 29237A UY 29237 A UY29237 A UY 29237A UY 29237 A1 UY29237 A1 UY 29237A1
Authority
UY
Uruguay
Prior art keywords
prevention
treatment
methods
xylopyranoside
benzopyran
Prior art date
Application number
UY29237A
Other languages
English (en)
Inventor
Jeffrey W Dubb
Linda S Henderson
Shunichiro S Okada
Vincent Peyrou
Robert E Samuels
Sunita Sheth
Patricia A Spera
John R Toomey
Douglas E Wilson
Original Assignee
Glaxo Group Ltd
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36565378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29237(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd, Fournier Lab Sa filed Critical Glaxo Group Ltd
Publication of UY29237A1 publication Critical patent/UY29237A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)

Abstract

Se describen métodos para el tratamiento y/o la prevención de trastornos tromboembólicos, que comprenden administrar 4-metil-2-oxo-2H-1-benzopiran-7-il-5-tio-B(beta))-D-xilopiranósido en candidades eficaces.
UY29237A 2004-12-01 2005-11-29 Metodos detratamiento y prevencion UY29237A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63215304P 2004-12-01 2004-12-01
US69172805P 2005-06-17 2005-06-17
US72169105P 2005-09-29 2005-09-29
US72471005P 2005-10-07 2005-10-07

Publications (1)

Publication Number Publication Date
UY29237A1 true UY29237A1 (es) 2006-05-31

Family

ID=36565378

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29237A UY29237A1 (es) 2004-12-01 2005-11-29 Metodos detratamiento y prevencion

Country Status (5)

Country Link
AR (1) AR053789A1 (es)
PE (1) PE20061246A1 (es)
TW (1) TW200635580A (es)
UY (1) UY29237A1 (es)
WO (1) WO2006060647A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801055B1 (fr) * 1999-11-17 2002-02-08 Fournier Ind & Sante Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
PE20061246A1 (es) 2006-11-08
WO2006060647A1 (en) 2006-06-08
AR053789A1 (es) 2007-05-23
TW200635580A (en) 2006-10-16

Similar Documents

Publication Publication Date Title
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
ECSP10010007A (es) Tratamiento con ligandos alpha-7-selectivos
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
ECSP077421A (es) Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1
MY147247A (en) Organic compounds and their uses
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
CL2007002635A1 (es) Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion.
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2009009417A3 (en) Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion
EP2069377A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
CY1111762T1 (el) Διενυδρη παμοϊκη ολανζαπiνη
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis